肉芽肿性小叶性乳腺炎诊治湖南专家共识(2021版)

2021-11-25 湖南省健康管理学会乳腺甲状腺健康管理专业委员会 中国普通外科杂志

肉芽肿性小叶性乳腺炎(GLM)是一种临床上较少见的乳腺慢性炎性疾病,近几年发病率有明显上升趋势。

中文标题:

肉芽肿性小叶性乳腺炎诊治湖南专家共识(2021版)

发布日期:

2021-11-25

简要介绍:

肉芽肿性小叶性乳腺炎(GLM)是一种临床上较少见的乳腺慢性炎性疾病,近几年发病率有明显上升趋势。但由于其病因不明、临床医师对该病认识不足,从而导致目前对该病的误诊率较高,特别是治疗不规范、效果欠佳,且病情易反复发作致迁延不愈,俗称“炎症中的癌症”。为此,湖南省健康管理学会乳腺甲状腺健康管理专业委员会、湖南省医学会普通外科学专业委员会乳腺甲状腺外科学组、湖南省预防医学会乳腺疾病防治专业委员会、湖南省中医药和中西结合学会外科专业委员会、湖南乳甲外科联盟5个学术机构,联合省内从事该领域相关专家,就GLM诊治相关内容,多次在线上和线下进行充分研讨,力求不断完善,基本达成共识,共同制定《肉芽肿性小叶性乳腺炎诊治湖南专家共识(2021版)》。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=肉芽肿性小叶性乳腺炎诊治湖南专家共识_2021版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b464f1c00229358b, title=肉芽肿性小叶性乳腺炎诊治湖南专家共识(2021版), enTitle=, guiderFrom=中国普通外科杂志, authorId=0, author=, summary=肉芽肿性小叶性乳腺炎(GLM)是一种临床上较少见的乳腺慢性炎性疾病,近几年发病率有明显上升趋势。, cover=https://img.medsci.cn/20211217/1639735195595_5579292.png, journalId=0, articlesId=null, associationId=2229, associationName=湖南省健康管理学会乳腺甲状腺健康管理专业委员会, associationIntro=湖南省健康管理学会乳腺甲状腺健康管理专业委员会, copyright=0, guiderPublishedTime=Thu Nov 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">肉芽肿性小叶性乳腺炎(GLM)是一种临床上较少见的乳腺慢性炎性疾病,近几年发病率有明显上升趋势。但由于其病因不明、临床医师对该病认识不足,从而导致目前对该病的误诊率较高,特别是治疗不规范、效果欠佳,且病情易反复发作致迁延不愈,俗称&ldquo;炎症中的癌症&rdquo;。为此,湖南省健康管理学会乳腺甲状腺健康管理专业委员会、湖南省医学会普通外科学专业委员会乳腺甲状腺外科学组、湖南省预防医学会乳腺疾病防治专业委员会、湖南省中医药和中西结合学会外科专业委员会、湖南乳甲外科联盟5个学术机构,联合省内从事该领域相关专家,就GLM诊治相关内容,多次在线上和线下进行充分研讨,力求不断完善,基本达成共识,共同制定《肉芽肿性小叶性乳腺炎诊治湖南专家共识(2021版)》。&nbsp;</span></p>, tagList=[TagDto(tagId=43195, tagName=乳腺外科), TagDto(tagId=119938, tagName=肉芽肿性小叶性乳腺炎)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=20598, guiderKeyword=乳腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2511, appHits=119, showAppHits=0, pcHits=476, showPcHits=2392, likes=0, shares=16, comments=6, approvalStatus=1, publishedTime=Fri Dec 17 17:31:35 CST 2021, publishedTimeString=2021-11-25, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Dec 17 17:37:20 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 18:52:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肉芽肿性小叶性乳腺炎诊治湖南专家共识_2021版.pdf)])
肉芽肿性小叶性乳腺炎诊治湖南专家共识_2021版.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1242509, encodeId=0b2c1242509e1, content=肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8d55638235, createdName=ms5000001905885448, createdTime=Thu Sep 01 16:38:14 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186191, encodeId=5e75118619105, content=先学习,这个毛病很棘手, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9a5546263, createdName=ms9000001150818312, createdTime=Wed Jan 19 22:45:04 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183123, encodeId=e2c61183123b8, content=收获很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d25607381, createdName=ms3000000540880896, createdTime=Tue Jan 11 10:30:51 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083910, encodeId=88ab1083910ef, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d841405312, createdName=wangnanhlj, createdTime=Fri Dec 24 14:25:11 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081419, encodeId=1426108141938, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:53:15 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2022-09-01 ms5000001905885448

    肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242509, encodeId=0b2c1242509e1, content=肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8d55638235, createdName=ms5000001905885448, createdTime=Thu Sep 01 16:38:14 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186191, encodeId=5e75118619105, content=先学习,这个毛病很棘手, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9a5546263, createdName=ms9000001150818312, createdTime=Wed Jan 19 22:45:04 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183123, encodeId=e2c61183123b8, content=收获很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d25607381, createdName=ms3000000540880896, createdTime=Tue Jan 11 10:30:51 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083910, encodeId=88ab1083910ef, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d841405312, createdName=wangnanhlj, createdTime=Fri Dec 24 14:25:11 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081419, encodeId=1426108141938, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:53:15 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2022-01-19 ms9000001150818312

    先学习,这个毛病很棘手

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1242509, encodeId=0b2c1242509e1, content=肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8d55638235, createdName=ms5000001905885448, createdTime=Thu Sep 01 16:38:14 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186191, encodeId=5e75118619105, content=先学习,这个毛病很棘手, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9a5546263, createdName=ms9000001150818312, createdTime=Wed Jan 19 22:45:04 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183123, encodeId=e2c61183123b8, content=收获很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d25607381, createdName=ms3000000540880896, createdTime=Tue Jan 11 10:30:51 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083910, encodeId=88ab1083910ef, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d841405312, createdName=wangnanhlj, createdTime=Fri Dec 24 14:25:11 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081419, encodeId=1426108141938, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:53:15 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2022-01-11 ms3000000540880896

    收获很多

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1242509, encodeId=0b2c1242509e1, content=肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8d55638235, createdName=ms5000001905885448, createdTime=Thu Sep 01 16:38:14 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186191, encodeId=5e75118619105, content=先学习,这个毛病很棘手, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9a5546263, createdName=ms9000001150818312, createdTime=Wed Jan 19 22:45:04 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183123, encodeId=e2c61183123b8, content=收获很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d25607381, createdName=ms3000000540880896, createdTime=Tue Jan 11 10:30:51 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083910, encodeId=88ab1083910ef, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d841405312, createdName=wangnanhlj, createdTime=Fri Dec 24 14:25:11 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081419, encodeId=1426108141938, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:53:15 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-24 wangnanhlj

    好文

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1242509, encodeId=0b2c1242509e1, content=肉芽肿性乳腺炎比较少见,治疗充满挑战,湖南率先推出共识和指南,给全国起了表率,点赞! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8d55638235, createdName=ms5000001905885448, createdTime=Thu Sep 01 16:38:14 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186191, encodeId=5e75118619105, content=先学习,这个毛病很棘手, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9a5546263, createdName=ms9000001150818312, createdTime=Wed Jan 19 22:45:04 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183123, encodeId=e2c61183123b8, content=收获很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d25607381, createdName=ms3000000540880896, createdTime=Tue Jan 11 10:30:51 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083910, encodeId=88ab1083910ef, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d841405312, createdName=wangnanhlj, createdTime=Fri Dec 24 14:25:11 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081419, encodeId=1426108141938, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:53:15 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-18 微探

    学习学习

    0